Siegfried Holding AG (XSWX:SFZN) Research & Development: CHF46 Mil (TTM As of Dec. 2025)


XSWX:SFZN Siegfried Holding AG XSWX:SFZN
94 GF Score
Price CHF69.65
GF Value CHF91.94
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Siegfried Holding AG Research & Development?

Siegfried Holding AG XSWX:SFZN +1.60% 94 Research & Development is CHF46 Mil as of Dec. 2025. GuruFocus rates XSWX:SFZN with a GF Score™ of 94/100 and a GF Value™ of CHF91.94 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Siegfried Holding AG's Research & Development for the six months ended in Dec. 2025 was CHF24 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was CHF46 Mil.

Siegfried Holding AG  (XSWX:SFZN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Siegfried Holding AG Research & Development Related Terms

Siegfried Holding AG Research & Development Historical Data

* Premium members only.

The historical data trend for Siegfried Holding AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siegfried Holding AG Research & Development Chart

Siegfried Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.67 43.18 44.50 41.12 46.18

Siegfried Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.57 21.72 19.40 21.74 24.44
XSWX:SFZN
94GF Score
Siegfried Holding AG XSWX:SFZN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siegfried Holding AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF46 Mil mean?
Siegfried Holding AG (XSWX:SFZN) has a Research & Development of CHF46 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Siegfried Holding AG and its competitors.
Is Siegfried Holding AG's Research & Development too high?
Siegfried Holding AG's current Research & Development is CHF46 Mil. Overall, Siegfried Holding AG has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's Research & Development compare to ZTS and UTHR?
Siegfried Holding AG's Research & Development of CHF46 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Siegfried Holding AG and its competitors. Siegfried Holding AG's current Research & Development is CHF46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF91.94, compared to a current price of CHF69.65 — trading 24.2% below its estimated fair value. The current Research & Development is CHF46 Mil. Siegfried Holding AG's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current Research & Development is CHF46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?

Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued. The current stock price of CHF69.65 is trading 24.2% below its estimated GF Value™ of CHF91.94. GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:SFZN:

  • Research & Development: CHF46 Mil
  • GF Value™: CHF91.94 vs. price of CHF69.65 (24.2% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Siegfried Holding AG Business Description

Address Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
94GF Score

Get the complete analysis for XSWX:SFZN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF69.65
Price
CHF91.94
GF Value